Clinical data | |
---|---|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H17NO3 |
Molar mass | 235.283 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Eutylone (also known as β-keto-1,3-benzodioxolyl-N-ethylbutanamine, bk-EBDB, and N-ethylbutylone) is a stimulant and empathogenic compound developed in the 1960s,[1][2] which is classified as a designer drug.[3] It was first reported to the EMCDDA in 2014 and became widespread internationally in 2019-2020 following bans on the related compound ephylone.[4][5][6][7]
Sweden's public health agency suggested classifying eutylone as a hazardous substance, on September 25, 2019.[8]
Phenylalkyl- amines (other than cathinones) |
|
---|---|
Cyclized phenyl- alkylamines | |
Cathinones | |
Tryptamines | |
Chemical classes |